Darbesis Injection 40 mcg/0.4 ml contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia, particularly in patients with chronic kidney disease (CKD) and those undergoing chemotherapy for certain cancers. It helps increase red blood cell production, improving hemoglobin levels and reducing the need for blood transfusions.

This formulation allows for less frequent dosing compared to conventional erythropoietin, making it suitable for long-term anemia management under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each prefilled syringe contains:

• Darbepoetin Alfa 40 mcg in 0.4 ml

Mechanism of Action

Darbepoetin Alfa is a synthetic form of erythropoietin with an extended half-life. It binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their growth and differentiation into mature red blood cells. This results in increased red blood cell production and improved oxygen delivery throughout the body.

Indications

Darbesis Injection 40 mcg/0.4 ml is indicated for:

• Anemia associated with chronic kidney disease (CKD)
• Anemia in patients receiving chemotherapy for non-myeloid malignancies
• Reduction in the need for blood transfusions
• Treatment of anemia due to insufficient endogenous erythropoietin production

Dosage and Administration

• Administered via subcutaneous (SC) or intravenous (IV) injection under medical supervision
• Dosage is individualized based on body weight, hemoglobin levels, and clinical response
• Typically administered once weekly or once every two weeks
• Regular monitoring of hemoglobin is essential
• Dose adjustments should be made carefully to maintain target hemoglobin levels

Contraindications

Darbesis Injection should not be used in:

• Known hypersensitivity to Darbepoetin Alfa or related products
• Uncontrolled hypertension
• Pure red cell aplasia after prior ESA therapy
• Severe allergic reactions to any component of the formulation

Side Effects

Possible side effects include:

• Increased blood pressure
• Headache
• Injection site reactions
• Edema (fluid retention)
• Thromboembolic events (e.g., deep vein thrombosis)
• Fever or flu-like symptoms
• Rare hypersensitivity reactions

Precautions

• Blood pressure should be well controlled before starting therapy
• Monitor hemoglobin levels regularly to avoid excessive rise
• Ensure adequate iron stores for optimal therapeutic response
• Use cautiously in patients with cardiovascular disease or history of stroke
• Should be used under strict medical supervision

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Darbesis Injection may interact with:

• Iron supplements (commonly co-administered)
• Antihypertensive drugs
• Other agents affecting erythropoiesis

Storage Conditions

• Store at 2°C to 8°C in a refrigerator
• Do not freeze or shake
• Protect from light
• Keep out of reach of children.